219 related articles for article (PubMed ID: 16466852)
1. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis.
Fukasawa K; Fujii H; Saitoh Y; Koizumi K; Aozuka Y; Sekine K; Yamada M; Saiki I; Nishikawa K
Cancer Lett; 2006 Nov; 243(1):135-43. PubMed ID: 16466852
[TBL] [Abstract][Full Text] [Related]
2. Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3.
Yang E; Shim JS; Woo HJ; Kim KW; Kwon HJ
Biochem Biophys Res Commun; 2007 Nov; 363(2):336-41. PubMed ID: 17888402
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
5. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
6. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.
Fukushima K; Miyamoto S; Tsukimori K; Kobayashi H; Seki H; Takeda S; Kensuke E; Ohtani K; Shibuya M; Nakano H
Biol Reprod; 2005 Jul; 73(1):172-9. PubMed ID: 15788755
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition.
Dye J; Lawrence L; Linge C; Leach L; Firth J; Clark P
Endothelium; 2004; 11(3-4):151-67. PubMed ID: 15370292
[TBL] [Abstract][Full Text] [Related]
9. Reduction of angiocidin expression in human umbilical vein endothelial cells via siRNA silencing inhibits angiogenesis.
Yang X; Rothman VL; L'Heureux DZ; Tuszynski G
Exp Mol Pathol; 2006 Oct; 81(2):108-14. PubMed ID: 16904104
[TBL] [Abstract][Full Text] [Related]
10. Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis.
Moehler TM; Sauer S; Witzel M; Andrulis M; Garcia-Vallejo JJ; Grobholz R; Willhauck-Fleckenstein M; Greiner A; Goldschmidt H; Schwartz-Albiez R
J Cell Physiol; 2008 Apr; 215(1):27-36. PubMed ID: 18205178
[TBL] [Abstract][Full Text] [Related]
11. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells.
Son KN; Hwang J; Kwon BS; Kim J
Biochem Biophys Res Commun; 2006 Feb; 340(2):498-504. PubMed ID: 16378600
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.
Thaloor D; Singh AK; Sidhu GS; Prasad PV; Kleinman HK; Maheshwari RK
Cell Growth Differ; 1998 Apr; 9(4):305-12. PubMed ID: 9563850
[TBL] [Abstract][Full Text] [Related]
14. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
15. Subtractive transcriptomics: establishing polarity drives in vitro human endothelial morphogenesis.
Glesne DA; Zhang W; Mandava S; Ursos L; Buell ME; Makowski L; Rodi DJ
Cancer Res; 2006 Apr; 66(8):4030-40. PubMed ID: 16618722
[TBL] [Abstract][Full Text] [Related]
16. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
17. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen.
Hotchkiss KA; Basile CM; Spring SC; Bonuccelli G; Lisanti MP; Terman BI
Exp Cell Res; 2005 Apr; 305(1):133-44. PubMed ID: 15777794
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.
Battle TE; Lynch RA; Frank DA
Cancer Res; 2006 Apr; 66(7):3649-57. PubMed ID: 16585190
[TBL] [Abstract][Full Text] [Related]
19. Gene silencing of human RAMP2 mediated by short-interfering RNA.
Albertin G; Ruggero M; Guidolin D; Nussdorfer GG
Int J Mol Med; 2006 Oct; 18(4):531-5. PubMed ID: 16964401
[TBL] [Abstract][Full Text] [Related]
20. Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases.
Wu J; Sheibani N
J Cell Biochem; 2003 Sep; 90(1):121-37. PubMed ID: 12938162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
